Search clinical trials for: Revlimid (lenalidomide)
Total 1058 results
-
Arbeitsgemeinschaft medikamentoese TumortherapieCelgene CorporationUnknownChronic Myelomonocytic LeukemiaAustria
-
University Hospital, LilleCelgene CorporationCompletedWaldenstrom MacroglobulinemiaFrance
-
Columbia UniversityCelgene CorporationActive, not recruiting
-
University Health Network, TorontoCelgene CorporationCompleted
-
MD Anderson International Spain SACelgene CorporationCompletedChronic Lymphocytic LeukemiaSpain
-
Johns Hopkins All Children's HospitalTerminatedCentral Nervous System TumorsUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...TerminatedMyelodysplastic SyndromeUnited States
-
CelgeneCompletedMantle Cell LymphomaUnited States, France, Belgium, Austria, Israel, Singapore, Spain, United Kingdom, Hungary, Colombia, Germany, Italy, Turkey, Puerto Rico
-
Universitätsklinikum Hamburg-EppendorfCompleted
-
Celgene CorporationICON Clinical ResearchCompletedMyelodysplastic SyndromesGermany, Israel, United Kingdom, Spain, Belgium, Italy, France, Netherlands, Sweden
-
CelgeneCompletedLymphoma, Non-Hodgkin'sUnited States, Spain, Germany, France, Italy, Canada, United Kingdom
-
Center for International Blood and Marrow Transplant...Celgene Corporation; National Marrow Donor ProgramCompletedMultiple MyelomaUnited States
-
Technische Universität DresdenCelgene CorporationTerminatedMyelodysplastic Syndromes | Acute Myelogenous LeukemiaGermany
-
Sutter Medical FoundationCompleted
-
Brown UniversityMemorial Hospital of Rhode Island; Roger Williams Medical CenterCompleted
-
CelgeneCompleted
-
CelgeneActive, not recruitingMultiple MyelomaNetherlands, Belgium, Denmark, Germany, United Kingdom, France, Norway, Spain, Austria, Ireland, Italy, Sweden
-
Leslie AndritsosCelgene CorporationCompletedAcute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Chronic Lymphocytic LeukemiaUnited States
-
CelgeneTerminatedMultiple MyelomaChina
-
Nordic MDS GroupCompleted
-
University Hospital, ToulouseCelgene; Intergroupe Francophone du MyelomeCompleted
-
CelgeneCompletedChronic Lymphocytic Leukemia | Leukemia, B-Cell, ChronicCanada, United States, Germany, Italy, Spain, Sweden, United Kingdom
-
Peter MacCallum Cancer Centre, AustraliaCelgene CorporationUnknownMyelodysplasiaAustralia
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Brigham... and other collaboratorsCompletedGlioblastoma | Gliosarcoma | Malignant GliomasUnited States
-
Celgene CorporationCompletedRadiculopathyUnited States
-
CelgeneCompletedMultiple MyelomaUkraine, Russian Federation
-
King's College Hospital NHS TrustCompleted
-
M.D. Anderson Cancer CenterCelgene CorporationCompleted
-
Swiss Group for Clinical Cancer ResearchTerminatedLymphomaSwitzerland, Norway, Sweden
-
Boston VA Research Institute, Inc.Celgene Corporation; Edward Hines Jr. VA Hospital; Michael E. DeBakey VA Medical... and other collaboratorsCompletedMultiple MyelomaUnited States
-
German CLL Study GroupCelgeneCompletedChronic Lymphocytic LeukemiaGermany
-
Celgene CorporationTerminatedComplex Regional Pain Syndrome, Type IUnited States
-
TelikCompletedMyelodysplastic SyndromeUnited States
-
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.Not yet recruitingB-cell Non-Hodgkin's Lymphoma
-
National Cancer Institute (NCI)CompletedAdult Acute Megakaryoblastic Leukemia (M7) | Adult Acute Minimally Differentiated Myeloid Leukemia (M0) | Adult Acute Monoblastic Leukemia (M5a) | Adult Acute Monocytic Leukemia (M5b) | Adult Acute Myeloblastic Leukemia With Maturation (M2) | Adult Acute Myeloblastic Leukemia Without Maturation... and other conditionsUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteCelgeneCompleted
-
Samyang Biopharmaceuticals CorporationChungnam National University HospitalCompleted
-
Lymphoma Study AssociationCompletedLymphoma, Large B-Cell, Diffuse | Follicular Lymphoma | Mantle Cell Lymphoma | Marginal Zone LymphomaFrance
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical Center; Genentech, Inc.; Brigham and Women's Hospital and other collaboratorsTerminatedWaldenstrom's MacroglobulinemiaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
National Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol Specific | Childhood Myelodysplastic Syndromes | Previously Treated Myelodysplastic Syndromes | Secondary Myelodysplastic Syndromes | de Novo Myelodysplastic Syndromes | Refractory Anemia | Refractory Anemia With Excess Blasts | Refractory Cytopenia With... and other conditionsUnited States
-
University Hospital, ToulouseCelgene Corporation; Janssen-Cilag Ltd.Completed
-
Marcelo Pasquini, MDNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute... and other collaboratorsActive, not recruiting
-
Merck Sharp & Dohme LLCCompletedFollicular Lymphoma | Diffuse Large B-Cell Lymphoma | Multiple Myeloma | Hodgkin Lymphoma | Non-Hodgkin Lymphoma | Myelodysplastic Syndrome | Primary Mediastinal B-Cell Lymphoma
-
Seoul National University HospitalUnknownAmyloidosis CardiacKorea, Republic of
-
The Lymphoma Academic Research OrganisationCompletedFollicular Lymphoma Patients (Phase IB) | Follicular and Agressive (DLBCL&MCL) B-cell Lymphoma Patients (Phase II)France, Belgium
-
Celgene CorporationTerminatedColorectal CancerAustralia, Belgium, Germany, Italy, Spain, Sweden
-
University of California, San DiegoCelgene CorporationCompletedChronic Lymphocytic Leukemia | CLLUnited States
-
Seagen Inc.CompletedMyelodysplastic Syndrome (MDS)United States